<?xml version="1.0" encoding="UTF-8"?><ns2:project xmlns:ns1="http://gtr.rcuk.ac.uk/gtr/api" xmlns:ns2="http://gtr.rcuk.ac.uk/gtr/api/project" xmlns:ns3="http://gtr.rcuk.ac.uk/gtr/api/fund" xmlns:ns4="http://gtr.rcuk.ac.uk/gtr/api/person" xmlns:ns5="http://gtr.rcuk.ac.uk/gtr/api/project/outcome" xmlns:ns6="http://gtr.rcuk.ac.uk/gtr/api/organisation" ns1:created="2026-08-26T13:36:10Z" ns1:href="http://gtr.ukri.org/gtr/api/projects/B4129AB8-A0E3-4EE7-BBAC-07881F065434" ns1:id="B4129AB8-A0E3-4EE7-BBAC-07881F065434"><ns1:links><ns1:link ns1:href="http://gtr.ukri.org/gtr/api/persons/587C0469-AB13-4A57-BBA2-219AF00BD991" ns1:rel="PM_PER"/><ns1:link ns1:href="http://gtr.ukri.org/gtr/api/organisations/55F1CF21-9495-40A5-B44F-50DA3AFA61FB" ns1:rel="LEAD_ORG"/><ns1:link ns1:href="http://gtr.ukri.org/gtr/api/organisations/55F1CF21-9495-40A5-B44F-50DA3AFA61FB" ns1:rel="PARTICIPANT_ORG"/><ns1:link ns1:end="2023-12-31T00:00:00Z" ns1:href="http://gtr.ukri.org/gtr/api/funds/4DFD01AC-5BCB-40C3-8260-E675126A1C95" ns1:rel="FUND" ns1:start="2023-06-30T23:00:00Z"/></ns1:links><ns2:identifiers><ns2:identifier ns2:type="RCUK">10075383</ns2:identifier></ns2:identifiers><ns2:title>Future Materials for the control of airborne disease transmission with the next generation of face masks</ns2:title><ns2:status>Closed</ns2:status><ns2:grantCategory>Grant for R&amp;D</ns2:grantCategory><ns2:leadFunder>Innovate UK</ns2:leadFunder><ns2:abstractText>Paravir has developed an **antiviral**, **disposable material** technology for facemasks and other medical nonwovens. Our technology is **recyclable, safe for humans, animals, marine and plant life.** It is also **incredibly cheap to make** meaning antiviral masks can become a standard intervention for variants of Covid 19 (SARS CoV19) and Bird Flu (H5N1).

We are seeking grant funding for the construction of a pilot line machine to evaluate the manufacturability of our antimicrobial application. This innovation adds function to off-the-shelf nonwovens which interfere and denature virus, bacteria, fungi and parasites reducing the user's exposure to infectious diseases. Our technology has recently been granted a UK Patent. Product testing has passed ISO 18184 (Antiviral) and ISO 20743 (Antibacterial) Materials.</ns2:abstractText></ns2:project>